Plasma enterolactone and genistein and the risk of premenopausal breast cancer

European Journal of Cancer Prevention

Volumn 15, Issue 3, 2006, Pages 225-232

  Piller, Regina ^a   Chang Claude, Jenny ^b   Linseisen, Jakob ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breast cancer; Enterolactone; Genistein; Isoflavonoids; Lignans; Phytoestrogens; Plasma; Premenopausal women

Indexed keywords

BIOLOGICAL MARKER; ENTEROLACTONE; GENISTEIN; ISOFLAVONE; LIGNAN; PHYTOESTROGEN;

ADULT; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; POPULATION RESEARCH; PREMENOPAUSE; PRIORITY JOURNAL;

4-BUTYROLACTONE; ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIET; FEMALE; GENISTEIN; HUMANS; LIGNANS; MIDDLE AGED; PHYTOESTROGENS; PLANT PREPARATIONS; PREMENOPAUSE; RISK FACTORS;

EID: 33646920929     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000197449.56862.75     Document Type: Article

References (46)

1. Adlercreutz H (1998). Epidemiology of phytoestrogens. Baillière's Clin Endocrinol Metab 12:605-623.
2. Adlercreutz H, Wang GJ, Lapcik O, Hampl R, Wahala K, Makela T, et al. (1998). Time-resolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 265:208-215.
3. Arai Y, Uehara M, Sato Y (2000). Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion of phytoestrogen intake. J Epidemiol 10:127-135.
4. Benassayag C, Perrot-Applanat M, Ferre F (2002). Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci 777:233-248.
5. Boccardo F, Lunardi G, Guglielmini P, Parodi M, Murialdo R, Schettini G, Rubagotti A (2004). Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 40:84-89.
6. Chang-Claude J, Eby N, Kiechle M, Bastert G, Becher H (2000). Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control 11:687-695.
7. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, et al. (2002). Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11:815-821.
8. den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH (2000). Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 10:223-228.
9. Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, et al. (2004). Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 13:698-708.
10. Hausner H, Johnsen NF, Hallund J, Tetens I (2004). A single measurement is inadequate to estimate enterolactone levels in Danish postmenopausal women due to large intraindividual variation. J Nutr 134:1197-1200.
11. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, Deyama T, et al. (2001). In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49:3178-3186.
12. Hermann S, Linseisen J, Chang-Claude J (2002). Nutrition and breast cancer risk by age 50: a population-based case-control study in Germany. Nutr Cancer 44:23-34.
13. Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, et al. (2001). Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 154:434-441.
14. Horn-Ross PL, Hoggatt KJ, West DW, Krone MR, Stewart SL, Anton H, et al. (2002). Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 13:407-415.
15. Hulten K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G, et al. (2002). An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 41:168-176.
16. Ingram D, Sanders K, Kolybaba M, Lopez D (1997). Case-control study of phytooestrogens and breast cancer. Lancet 350:990-994.
17. Keinan-Boker L, van der Schouw YT, Grobbee DE, Peeters PH (2004). Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79:282-288.
18. Kilkkinen A, Stumpf K, Pietinen P, Valsta LM, Tapanainen H, Adlercreutz H, et al. (2001). Determinants of serum enterolactone concentration. Am J Clin Nutr 73:1094-1100.
19. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H, et al. (2002). Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 155:472-477.
20. Kilkkinen A, Virtamo J, Vartiainen E, Sankila R, Virtanen MJ, Adlercreutz H, Pietinen P (2004). Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 108:277-280.
21. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000a). Daidzein and genistein contents of vegetables. Br J Nutr 84:717-725.
22. Liggins J, Bluck LJC, Runswick S, Atinson C, Coward WA, Bingham SA (2000b). Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11:326-331.
23. Linseisen J, Piller R, Hermann S, Chang-Claude J (2004). Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 110:284-290.
24. Magee PJ, Rowland IR (2004). Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91:513-531.
25. Mazur W (1998). Phytoestrogen content in foods. Baillière's Clin Endocrinol Metab 12:729-742.
26. McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG (2002). The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 132:3036-3041.
27. McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Frudenheim JL (2004). Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer 111:440-443.
28. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA (2002). Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 132:3168-3171.
29. Nesbitt PD, Lam Y, Thompson LU (1999). Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69:549-555.
30. Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, Adlercreutz H (2001). Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 10:339-344.
31. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA (2000). Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36:27-32.
32. Setchell KD, Cole SJ (2003). Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. J Agric Food Chem 51:4146-4155.
33. Stumpf K, Adlercreutz H (2003). Short-term variations in enterolactone in serum, 24-hour urine, and spot urine and relationship with enterolactone concentrations. Clin Chem 49:178-181.
34. Stumpf K, Uehara M, Nurmi T, Adlercreutz H (2000). Changes in the time-resolved fluoroimmunoassay of plasma enterolactone. Anal Biochem 284:153-157.
35. Thompson LU, Rickard SE, Cheung F, Kenaschuk EO, Obermeyer WR (1997). Variability in anticancer lignan levels in flaxseed. Nutr Cancer 27:26-30.
36. Uehara M, Arai Y, Wantanabe S, Adlercreutz H (2000). Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay. Biofactors 12:217-225.
37. Valentin-Blasini L, Blount BC, Caudill SP, Needham LL (2003). Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 13:276-282.
38. Verkasalo PK, Appleby PN, Allen NE, Davey G, Adlercreutz H, Key TJ (2001). Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition). Br J Nutr 86:415-421.
39. Wang GJ, Lapcik O, Hampl R, Uehara M, Al-Maharik N, Stumpf K, et al. (2000). Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids 65:339-348.
40. Wang J, Murphy PA (1994). Isoflavone composition of American and Japanese soybeans in Iowa: Effects of variety, crop year, and location. J Agric Food Chem 42:1674-1677.
41. Wang LQ (2002). Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777:289-309.
42. Yamamoto S, Sobue T, Sasaki S, Kobayashi M, Arai Y, Uehara M, et al. (2001). Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131:2741-2747.
43. Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkhanov A, Toniolo P (1998). Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period. Cancer Epidemiol Biomarkers Prev 7:885-889.
44. Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, Koenig KL, Kato I, Arslan AA, Toniol P (2004). Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 91:99-105.
45. Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA (1999). Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8:35-40.
46. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, et al. (1993). Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819-1827.